Raquel Torres
Impact in
Papers in
-
- Advanced Breast Cancer Therapies 5
- Oncology 5
- Cancer-related Molecular Pathways 5
- HER2/EGFR in Cancer Research 2
- Co-authors
- Marı́a José Lallena (5 shared papers)Alfonso de Dios (4 shared papers)Concepción Sánchez‐Martínez (2 shared papers)Miriam Del Prado (2 shared papers)Blake Lee Neubauer (2 shared papers)Emiko L. Kreklau (2 shared papers)Jamie Young (2 shared papers)Edward M. Chan (2 shared papers)
- Journals
- Cancer Research (3 papers)Molecular Cancer Therapeutics (1 paper)Frontiers in Oncology (1 paper)Investigational New Drugs (1 paper)Physiological Genomics (1 paper)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Raquel Torres
8 papers receiving 679 citations
Hit Papers
Peers
Comparison fields: 5 of 69
- Oncology 412
- Genetics 141
- Pulmonary and Respiratory Medicine 416
- Cardiology and Cardiovascular Medicine 137
- Endocrinology, Diabetes and Metabolism 84
Countries citing papers authored by Raquel Torres
This map shows the geographic impact of Raquel Torres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raquel Torres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raquel Torres more than expected).
Fields of papers citing papers by Raquel Torres
This network shows the impact of papers produced by Raquel Torres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raquel Torres. The network helps show where Raquel Torres may publish in the future.
Co-authors
The 25 scholars most cited alongside Raquel Torres, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine Hit paper breakdown → | 2014 | 446 |
| 2 | 2006 | 165 | |
| 3 | 2006 | 26 | |
| 4 | 2015 | 21 | |
| 5 | 2011 | 14 | |
| 6 | 2016 | 13 | |
| 7 | 2016 | 5 | |
| 8 | 2016 | 3 |
About Raquel Torres
Raquel Torres is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cell Biology and Surgery, having authored 8 papers that have together received 693 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (5 papers), Cancer-related Molecular Pathways (5 papers), HER2/EGFR in Cancer Research (2 papers), Connexins and lens biology (1 paper), Advanced Glycation End Products research (1 paper), Calpain Protease Function and Regulation (1 paper), Renin-Angiotensin System Studies (1 paper) and Hormonal Regulation and Hypertension (1 paper). The work is most often cited by research in Oncology (412 citations), Genetics (141 citations), Pulmonary and Respiratory Medicine (416 citations), Cardiology and Cardiovascular Medicine (137 citations) and Endocrinology, Diabetes and Metabolism (84 citations). Raquel Torres has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Marı́a José Lallena, Alfonso de Dios, Concepción Sánchez‐Martínez, Miriam Del Prado, Blake Lee Neubauer, Emiko L. Kreklau, Jamie Young, Edward M. Chan, Damien M. Cronier and Graham N. Wishart. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Frontiers in Oncology, Investigational New Drugs and Physiological Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.